They found that the upregulation of the growth arrest specific 6-antisense 2 (GAS6-AS2) lncRNA leads to the hyperactivation of the GAS6/TAM pathway, which is an important resistance mechanism in multiple cancer types. This evidence concerns the gene GAS6 and cancer.